Description

1H-Pyrrolizine-1,2,7-Triol, 3-(Diethylamino)Methylhexahydro-, Triacetate (Ester), 1R-(1.Alpha.,2.Beta.,3.Alpha.,7.Beta.,7A.Alpha.)- is a high-purity, complex organic compound with a defined stereochemistry, serving as a critical advanced intermediate in pharmaceutical synthesis. Its value lies in providing a sophisticated chiral scaffold for the development of novel active pharmaceutical ingredients (APIs), particularly in neurological and metabolic research. This product is essential for R&D chemists and process development scientists in the pharmaceutical, biotechnology, and fine chemical industries seeking reliable, high-quality building blocks for complex molecule construction.

Application

• Pharmaceutical Intermediate: A key chiral building block for the synthesis of novel drug candidates targeting complex biological pathways.
• Neurological Research: Used in the development of compounds for studying and treating neurological disorders.
• Metabolic Disease Research: Serves as a precursor in the creation of molecules for metabolic syndrome and diabetes research.
• Process Chemistry & Scale-Up: Employed in route scouting and optimization for the commercial-scale production of specialty APIs.
• Asymmetric Synthesis: Utilized as a stereochemically defined template to introduce complexity in asymmetric catalytic reactions.
• Academic & Institutional R&D: A valuable reagent for universities and research institutes conducting cutting-edge medicinal chemistry projects.

Basic Information

Item	Details
Product Name	1H-Pyrrolizine-1,2,7-Triol, 3-(Diethylamino)Methylhexahydro-, Triacetate (Ester), 1R-(1.Alpha.,2.Beta.,3.Alpha.,7.Beta.,7A.Alpha.)-
CAS No.	156205-88-8
Molecular Formula	C18H31NO6
Molecular Weight	357.45 g/mol
Synonyms	1R-(1α,2β,3α,7β,7aα)-Hexahydro-3-[(diethylamino)methyl]-1,2,7-trihydroxy-1H-pyrrolizine Triacetate (Ester); (1R,2R,3R,7S,7aR)-3-[(Diethylamino)methyl]hexahydro-1,2,7-trihydroxy-1H-pyrrolizine-1,2,7-triyl Triacetate; 3-(Diethylaminomethyl)hexahydro-1H-pyrrolizine-1,2,7-triol Triacetate; 156205-88-8; Pyrrolizine triacetate derivative; 3-Diethylaminomethylhexahydropyrrolizinetriol triacetate
EINECS	Contact for details

Quality Control

Our 1H-Pyrrolizine-1,2,7-Triol, 3-(Diethylamino)Methylhexahydro-, Triacetate (Ester) is manufactured under strict quality management systems to ensure batch-to-batch consistency and high purity. Production adheres to cGMP (current Good Manufacturing Practice) guidelines where applicable, and each lot is supported by a comprehensive Certificate of Analysis (COA) detailing identity, purity, and impurity profiles. We are committed to meeting the stringent requirements of pharmaceutical R&D and production.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry place at a controlled room temperature (15-25°C). This product is hygroscopic (moisture-sensitive) and light-sensitive; containers must be kept tightly sealed in a dry environment and opened only under controlled conditions to minimize exposure to moisture and light.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference standard
Assay (HPLC)	≥ 98.0%
Related Substances (HPLC)	Total impurities ≤ 2.0% Any single impurity ≤ 1.0%
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%
Specific Rotation	Contact for details

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.